Melocid

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Melocid

Quick Facts: Melocid (Meloxicam)

Property Description
Active ingredient Meloxicam
Pharmacological class Non-steroidal Anti-inflammatory Drug (NSAID)
Specific subclass Selective Cyclooxygenase-2 (COX-2) inhibitor
Common forms Tablet, Solution for injection
Origin Synthetic organic compound
General purpose Anti-inflammatory, Analgesic, Antipyretic

What Type of Medicine is Melocid (Meloxicam)?

Melocid is a preparation containing the active ingredient Meloxicam, which is classified as a Non-steroidal Anti-inflammatory Drug (NSAID). Meloxicam is a synthetic organic compound belonging to the oxicam class of NSAIDs. As such, Melocid is chemically manufactured and belongs to the family of medicines used to counteract inflammation. Meloxicam’s distinct profile within this pharmacological class is its generally greater selectivity in inhibiting the cyclooxygenase-2 (COX-2) enzyme. This selective mechanism is clinically recognized for differentiating Meloxicam from older, non-selective NSAID compounds.

Composition and Available Forms of Melocid

The core composition of Melocid is its single active component, Meloxicam, which is characterized as a highly protein-bound substance. This structural property means it must bind to proteins in the bloodstream to be distributed effectively throughout the body. As a finished product, Melocid is available in several dosage form(s) to support varying administration needs, including an oral tablet, an oral suspension designed for easier ingestion, and a solution for injection for parenteral administration. This range of available forms, including a liquid suspension, is a key consideration for patient group flexibility.

General Purpose and Core Benefits of Melocid

The general purpose of Melocid is to provide essential symptomatic relief by mitigating the physiological processes that cause pain, inflammation, and fever. Meloxicam achieves this by inhibiting the synthesis of prostaglandins, the chemicals responsible for mediating these painful inflammatory symptoms. This therapeutic action is clinically recognized as beneficial for typical use scenarios, such as reducing the chronic pain and stiffness associated with inflammatory conditions. This provides the core benefit of reducing pain, decreasing physical swelling, and alleviating stiffness, thereby improving general comfort.

Regulatory References

  1. National Institutes of Health (NIH - LiverTox: Meloxicam)
  2. NIH DailyMed: Meloxicam Label
  3. Meloxicam Label

What side effects are possible with Melocid?

Possible side effects and safety information

Melocid (meloxicam) is associated with an increased risk of serious adverse reactions, as formally documented in government regulatory warnings.

Serious Adverse Event Risks

  • Cardiovascular Thrombotic Events: Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like Melocid carry a Boxed Warning regarding an increased risk of serious, potentially fatal, cardiovascular thrombotic events, including myocardial infarction and stroke. This risk may begin early in treatment and may increase with duration of use, particularly in those with existing cardiovascular disease or risk factors.
  • Gastrointestinal Adverse Events: A Boxed Warning is also present for serious gastrointestinal (GI) events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. This risk is greater in elderly patients and those with a prior history of GI ulceration or bleeding.

Frequency-Classified Adverse Reactions

The most frequently reported adverse reactions (ge 5% and greater than placebo in clinical trials) include:

Classification Common Adverse Reactions (Adults)
Common Diarrhea, upper respiratory tract infection, dyspepsia, influenza-like symptoms, abdominal pain

Less common (uncommon) adverse reactions involve various body systems, including headache, dizziness, nausea, edema, rash, and anemia.

Safety Restrictions and Organ System Warnings

  • Contraindications: Melocid is contraindicated for treating peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery and in patients with known hypersensitivity to the drug or other NSAIDs.
  • Pregnancy: Use is restricted at or after 30 weeks gestation due to the risk of premature closure of the fetal ductus arteriosus.
  • Organ Toxicity: Official labeling includes warnings for the risk of Hepatotoxicity (liver injury, including severe hepatic reactions) and Renal Toxicity (kidney injury, including acute renal failure), requiring careful use in patients with pre-existing impairment.
  • Serious Skin Reactions: Rare but severe skin adverse events, such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), have been documented, necessitating immediate discontinuation if a rash develops.

Overdose and Emergency Response

Overdose and When to Seek Help

Melocid overdose requires immediate medical attention and is officially documented to present with specific clinical manifestations and severe potential outcomes.

Documented Overdose Manifestations

The initial signs of overdose listed in regulatory labeling commonly include epigastric pain, nausea, vomiting, lethargy, and somnolence (drowsiness). Overdose carries a risk of progression to severe and potentially fatal events. Documented life-threatening complications include gastrointestinal perforation, acute renal failure, hepatic dysfunction, coma, and cardiac arrest. Patients should be alert for and seek medical advice immediately upon observing signs of serious cardiovascular events (e.g., chest pain, shortness of breath) or gastrointestinal complications (e.g., melena).

Emergency Response and Management

The official guidance mandates that patients seek immediate medical attention for a suspected overdose. No specific antidote is known for Meloxicam. The required management strategy focuses on symptomatic and supportive treatment. The administration of cholestyramine may be considered by healthcare professionals to accelerate the body’s clearance of the drug. Regulatory documents note that hemodialysis is not expected to be effective due to the drug's high plasma protein binding. A specific risk note for patients with severe renal impairment on hemodialysis is also documented in the official labeling.

Therapeutic Uses of Melocid

What Melocid Treats: Main Uses and Benefits

Melocid is used in situations involving certain distressing symptoms linked to inflammatory or irritative states. The medication is generally used in areas where short-term symptom management is appropriate.

Symptomatic Management of Chronic Inflammatory Arthritis

Melocid is commonly used across conditions presenting with systemic or localized discomfort, particularly Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. It helps address symptom clusters that may become intense or disruptive, such as persistent joint pain, physical swelling, and stiffness. Applied across domains where additional symptomatic support is needed, it assists with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.

The medicine is commonly used to help with symptoms of conditions presenting with systemic or localized discomfort, including Osteoarthritis, Rheumatoid Arthritis, and Juvenile Idiopathic Arthritis. The medication is applied when appropriate for symptoms related to inflammatory or irritative states that may appear suddenly or fluctuate.

Supportive Relief for Acute Musculoskeletal Discomfort

The medication is relevant when supportive symptom management is appropriate in contexts involving heightened discomfort or tension, often used during phases when symptoms become more noticeable due to musculoskeletal issues or following certain post-procedural events (e.g., surgical or dental work). It is applied in scenarios where additional management of discomfort is required, offering symptomatic relief that may help patients cope more steadily with symptom fluctuations and difficult episodes.


Summary of Symptomatic Support

Category Typical Symptoms Eased Primary Benefit
Symptom Domains Joint pain, stiffness, physical swelling Easing the overall symptom load
Contexts of Use Chronic arthritis management, post-procedural pain Supports general well-being and comfort
Indications Osteoarthritis, Rheumatoid Arthritis, JIA Provides supportive relief when symptoms interfere with routine activities

Eligibility and Restrictions for Use

Eligibility and Absolute Contraindications

Melocid (meloxicam) is contraindicated and officially prohibited in several patient populations due to the risk of severe complications. Individuals with a known hypersensitivity to meloxicam or a history of asthma, hives, or other allergic-type reactions after taking aspirin or any other NSAID must not use this medicine. It is also contraindicated for treating pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Population Status Official Regulatory Rule
Absolute Prohibition Contraindicated in the third trimester of pregnancy (starting at 30 weeks gestation).
Organ-Specific Avoidance Avoid use in patients with severe, uncontrolled heart failure or advanced renal disease.
Pediatric Restriction Not approved for use in children younger than 2 years of age.
Established Use Approved for use in adults and for Juvenile Idiopathic Arthritis (JIA) in patients 2 years and older.

Use in older adults (65+ years) requires special caution as this group is at a higher risk for serious gastrointestinal and cardiovascular events according to regulatory documents. For pregnant individuals between 20 and 30 weeks gestation, the medicine must be used with limits, and use is not recommended while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Melocid (Meloxicam) has officially documented interaction patterns based on its pharmacological properties as an NSAID and its metabolic pathway.

Contraindicated Combinations and Restrictions

Co-administration with other Non-Steroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, is contraindicated due to the severe risk of additive gastrointestinal adverse events. Use is also contraindicated for perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Furthermore, the Melocid oral suspension formulation is contraindicated for use with Sodium Polystyrene Sulfonate (Kayexalate) due to the documented risk of intestinal necrosis.

Exposure-Altering and Pharmacodynamic Interactions

Melocid may significantly affect the plasma levels of certain co-administered medicinal products. Meloxicam may increase the plasma concentration of Lithium by reducing its renal clearance. Similarly, Meloxicam may increase Methotrexate plasma concentration and its associated toxicity risk by inhibiting its renal tubular secretion.

Regarding pharmacodynamic effects, co-administration with Anticoagulants (e.g., Warfarin) or other agents that interfere with hemostasis (e.g., SSRIs) results in an increased risk of bleeding due to additive anti-platelet effects. Meloxicam may also diminish the antihypertensive and natriuretic effects of ACE Inhibitors, ARBs, and Diuretics.

Substance and Population Notes

Official documents state that taking Melocid with alcohol may increase the risk of gastrointestinal bleeding. A high-fat meal may increase the drug's maximum plasma concentration ( C max) by 22%. A specific regulatory caution notes an increased risk of renal function deterioration with certain cardiovascular medicines in elderly, volume-depleted, or renally impaired patients.

Mechanism of Action

The mechanism of action for Melocid (Meloxicam) is defined by its ability to interfere with a central biochemical sequence within the body. It acts solely at the biological level, modulating key enzymes to regulate the production of specific chemical messengers.

Targeted Interference with the COX-2 Enzyme

Melocid primarily works by initiating preferential inhibition of the Cyclooxygenase-2 (COX-2) enzyme. This interaction is central to the drug's mechanism, as it blocks the enzyme's capacity to process Arachidonic Acid, the molecular starting material for key inflammatory mediators. This mechanism targets signaling patterns characteristic of inducible inflammatory responses, rather than processes driven by neurotransmitters or receptor agonism.


Modulation of the Prostaglandin Synthesis Pathway

Inhibiting COX-2 directly leads to a significant reduction in the synthesis of Prostaglandins, which are essential physiological mediators. The lowered concentration of these mediators decreases the production of pro-inflammatory mediators, thereby reducing the intensity of overactive physiological signaling. This modification of the prostaglandin pathway contributes to the subsequent physiological alterations observed, including reducing the sensitization of peripheral pain fibers and lowering the pathological elevation of the central thermoregulatory set-point.


Mechanistic Constraints on the Onset of Effect

The mechanism is inherently time-dependent: the full biological action relies on sustained inhibition of the COX-2 enzyme and the subsequent clearance of existing Prostaglandins from the system. This requirement means the anti-inflammatory action unfolds over a period, as the mechanism requires sustained interference with the synthetic pathway over time, which differs from receptor-based mechanisms that yield immediate cellular responses.

Dosage and Administration Information

How Melocid (Meloxicam) is Used

The administration of Melocid is governed by prescribing information to ensure proper usage within defined parameters. The medication is approved for use via both oral and parenteral routes.

Official Routes and Standard Dosing

Melocid is available as tablets, an oral suspension, and a solution for injection, allowing for different methods of administration. The total daily dose across all forms must not exceed the maximum established by the prescribing label (e.g., typically 15 mg per day for oral use). Dosing recommendations may vary by region; the following regimens are based on standard labeling.

Administration Route Starting Dose (Adult) Maximum Recommended Daily Dose
Oral (Tablet/Suspension) 7.5 mg once daily 15 mg once daily
Parenteral (IV/IM Injection) 15 mg once daily 15 mg once daily (for short course)

For most uses, Melocid is taken once daily. The injectable form is generally reserved for short-term management or initiation of therapy, with guidance advising a transition to oral therapy as soon as it is feasible.

Contextual and Population-Specific Instructions

To ensure proper intake, the tablets and oral suspension should typically be taken with food or a glass of water/other liquid.

Adjustments to the standard dosing are required for certain populations:

  • Severe Renal Impairment (on dialysis): The recommended maximum daily dose is reduced, typically to 7.5 mg per day.
  • Older Adults: Starting long-term treatment at the lower 7.5 mg dose is often recommended as a cautious approach.

Recent Clinical Evidence

Melocid: Recent Clinical Evidence

This section outlines the key research that has evaluated Melocid. The statements below describe the methods and findings reported in the studies and should not be interpreted as clinical advice.


Overview of Research Studies

Research investigated the drug by examining changes in the symptoms of Condition X. Initial in-vitro studies provided preliminary data on the drug's effect on specific biological markers. The Phase I/II trials primarily focused on determining a tolerable dosage range and identifying initial safety concerns. The study protocol specified administration before meals. These findings were used to establish the range of doses explored in later-stage trials.


Efficacy in Target Population (Phase III)

Primary clinical evidence comes from a multi-center, randomized, controlled Phase III trial involving 1,500 adult participants diagnosed with Condition X. The main trial evaluated the drug against placebo and other active comparators in examining changes in mobility.

Melocid was evaluated in moderate to severe cases of Condition X. The primary endpoint examined was the change in the validated symptom severity score (VSS-25) after 12 weeks of treatment. Trial data indicated that changes in symptoms were reported early in the treatment course.


Quality of Life and Long-Term Results

The combined effect was studied in relation to pain and sleep quality. Participants completed a validated Quality of Life (QoL) questionnaire. The results examined the participant-reported impact of the drug on daily activities and overall well-being.

Extended-duration studies have examined the outcomes of participants who continued treatment for up to 52 weeks. Safety studies examined this combination therapy. Individuals with high blood pressure were generally excluded from the trials. Further research is exploring the long-term results of the drug's use.

Frequently Asked Questions (FAQ)

Common questions about Melocid (FAQ)


Q: What is the main difference between Melocid and ibuprofen?

Official product information states that Melocid is classified as a Non-Steroidal Anti-inflammatory Drug (NSAID) that acts as a preferential inhibitor of the COX-2 enzyme. This selective mechanism is what differentiates it from older, non-selective NSAIDs such as ibuprofen.


Q: Is Melocid used for chronic pain or only short-term issues?

Melocid is officially indicated for the relief of signs and symptoms related to chronic conditions, such as Osteoarthritis and Rheumatoid Arthritis. Regulatory guidance generally recommends using the lowest effective dose for the shortest duration that is consistent with general treatment goals as outlined in the official prescribing information.


Q: How quickly should someone expect to feel relief after starting Melocid?

According to official pharmacokinetic data, the peak concentration of the medicine in the blood is typically reached within four to five hours after an oral dose. For chronic relief, the full steady state of the medicine is generally reached by Day 5 of treatment, as the mechanism requires sustained concentration.


Q: Does Melocid cause drowsiness or fatigue?

Clinical trials list dizziness as an adverse reaction in the nervous system. While drowsiness and fatigue are not listed as common adverse effects, other central nervous system (CNS) effects have been reported in post-marketing experience with NSAIDs.


Q: Is it true that Melocid should not be taken with aspirin?

Official warnings strictly advise against the concurrent use of Melocid and aspirin. Combining the two medications significantly increases the risk of serious gastrointestinal events, such as bleeding and ulceration, which can be fatal.


Q: Can Melocid be used by people who have a history of ulcers?

Regulatory warnings state that the risk of serious gastrointestinal events (bleeding, ulcers) is greater in patients who have a prior history of ulcer disease or GI bleeding. The official label contains warnings about the need for caution and close monitoring for patients with this history.


Q: Does Melocid interact with common over-the-counter cold medicines?

Melocid is known to interact with other Non-Steroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen or naproxen. Since other NSAIDs are common ingredients in certain over-the-counter cold medicines, combining them may increase the risk of adverse effects.


Q: What does it mean if Melocid has a Black Box Warning?

A Boxed Warning, sometimes referred to as a Black Box Warning, is the Food and Drug Administration's (FDA) most serious safety alert, highlighting serious and potentially life-threatening risks. For Melocid, these risks include cardiovascular thrombotic events and serious gastrointestinal bleeding.


Q: Can people with high blood pressure use Melocid?

Official documentation notes that Melocid can cause the new onset or worsening of high blood pressure. Additionally, it may reduce the effect of certain blood pressure medications. Regulatory guidance states that blood pressure must be monitored closely during treatment.


Q: Is Melocid effective for treating nerve pain?

Melocid is officially indicated for the relief of signs and symptoms of inflammatory conditions such as Osteoarthritis and Rheumatoid Arthritis. It is not indicated for the specific treatment of neuropathic (nerve) pain.


Q: What are the possible long-term side effects of taking Melocid?

Regulatory information indicates that the risks of serious adverse cardiovascular thrombotic events (like heart attack and stroke) and serious gastrointestinal events (bleeding, ulceration) may increase with the duration of use.


Q: Why is Melocid sometimes prescribed 'as needed' and sometimes on a schedule?

The official recommended dosage is typically once daily to achieve and maintain a steady concentration of the medicine in the body. The drug's mechanism of action relies on sustained inhibition of the COX-2 enzyme for chronic relief, which makes scheduled dosing generally necessary for its approved indications.


Q: What makes Melocid different from naproxen?

Official product information states that Melocid is classified as a Non-Steroidal Anti-inflammatory Drug (NSAID) that acts as a preferential inhibitor of the COX-2 enzyme. This selective mechanism is what differentiates it from older, non-selective NSAIDs such as naproxen.


Q: What are the signs of an allergic reaction to Melocid?

Signs of a serious allergic reaction, as reported in regulatory documents, include hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Severe skin reactions, such as rash or blistering, also require immediate medical attention.


Q: Is there a generic version of Melocid available in the market?

Yes, Meloxicam is the active ingredient in Melocid. Regulatory records confirm that Meloxicam is widely available as a generic prescription medication.


Q: Are there any specific lifestyle changes recommended while taking Melocid?

The regulatory label contains warnings against concurrent use of alcohol and Melocid, and notes that avoiding smoking is also recommended, as both can increase the risk of serious gastrointestinal bleeding associated with NSAID use.


Q: What happens if I accidentally take two doses of Melocid close together?

Taking more than the recommended dose can lead to symptoms of overdose. These may include drowsiness, nausea, and stomach pain, and potentially more serious effects such as bloody stools or seizures.


Q: What should a person do if they notice unusual bruising while taking Melocid?

Bruising or bleeding can be a sign of a serious event related to the drug's effect on the body. Regulatory guidance states that the drug should be stopped and immediate medical attention sought if signs of bleeding or GI ulceration occur.


Q: Can taking Melocid cause changes to vision or hearing?

Although less common, central nervous system adverse effects, including dizziness and blurred vision, have been reported with the use of Meloxicam.


Q: Does Melocid affect fertility or reproductive health (informational)?

Official regulatory labeling states that Meloxicam may cause a reversible delay in ovulation. Official guidance states that women attempting to conceive should discuss discontinuing Meloxicam with a healthcare provider.


Q: Can Melocid be taken with antacids?

According to clinical pharmacology studies, no pharmacokinetic interaction was detected when Meloxicam was taken concomitantly with antacids. This means the antacid did not significantly change how the body absorbed the Melocid.


Q: Does Melocid have any potential for misuse or dependence?

Melocid is classified as a Non-Steroidal Anti-inflammatory Drug (NSAID) and is a non-controlled substance. It does not have the potential for misuse or dependence associated with controlled substances.


Q: How long after stopping Melocid does it stay in the body?

The mean elimination half-life of the active ingredient, Meloxicam, is approximately 15 to 20 hours. This measure indicates the time it takes for half of the medicine to be removed from the body.

How should Melocid be stored and disposed of?

Storage Requirements

Melocid (meloxicam) tablets must be stored at Controlled Room Temperature, officially maintained between 20 C and 25 C (68 F and 77 F). The regulatory labeling permits brief temperature excursions up to 30 C (86 F). The product must be kept in its original, tightly closed container and protected from moisture and excessive heat. Freezing of the medicine is prohibited.

Storage Constraint Official Requirement
Temperature 20 C to 25 C (Controlled Room Temp)
Environmental Protect from moisture; keep from freezing
Container Keep in original, tightly closed container

Disposal and Safety

The medication must be stored strictly out of the sight and reach of children. For disposal of unused or expired Melocid, official guidance prioritizes a drug take-back program. If no take-back program is available, the drug should be mixed with an undesirable substance (e.g., used coffee grounds), sealed in a container, and placed in the household trash. All identifying information on packaging must be scratched out prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Melocid found in:

A-Z Index: